TI Public Affairs Report
Texas Instruments
  Education
TI's Phil Ritter speaks to students, faculty and industry and elected officials at the announcement reception at UT Arlington
TI's Phil Ritter speaks to students, faculty and industry
and elected officials at the announcement reception at
UT Arlington.

Dr. Robert Magnusson has been named the Texas Instruments Distinguished University Chair in Nanoelectronics, a $5 million endowed chair for the University of Texas at Arlington (UT Arlington).

A $1 million gift from TI (part of the company’s investment in the Southwest Academy of Nanoelectronics) coupled with $1 million from UT Arlington make up a $2 million permanent endowment for the chair. Additional funding of $2.5 million provided by the state's Emerging Technology Fund, along with $500,000 from the UT system STARS Program, bring the total to $5 million.

Dr. Magnusson taught at UT Arlington from 1984-98. He served as chairman of the Department of Electrical Engineering from 1998-2001. He is also chief technology officer for Resonant Sensors Inc.

"We are so pleased that Dr. Magnusson has returned to Maverick country," said James D. Spaniolo, president of UT Arlington. "TI – always an insightful player in future technology – has seen how valuable Dr. Magnusson’s research is. And they have backed up that keen perception on staying ahead of the curve with a huge contribution to this endowed chair. We look forward to future collaborations with TI."

"TI’s grant makes a strong statement: we believe in the exciting future of nanoelectronics and in the solid research capabilities of UTA," said Philip J. Ritter, TI senior vice president of public affairs. "Research strength among our local universities is critical to the future success of our company and our region, and we are pleased to contribute to the funding of this chair."

Dr. Magnusson has developed a new class of nanostructured photonic devices, which have applications in lasers, sensors, solar cells and display technology. Near-term projects include commercialization of new biosensor platforms for drug discovery and medical diagnostics.

The technology could make drug discovery happen in real time instead of waiting hours, days or weeks for results.

"We’re looking forward to bringing more of these devices and processes to market," said Magnusson, who has already obtained dozens of patents on related technology. "We believe that our technology will help revolutionize the medical device and drug discovery industries."

"Nanoelectronics innovations will help solve some of the world’s most pressing problems, such as health care, energy efficiency and safety," said TI Senior Fellow Dr. Robert R. Doering. "Dr. Magnusson’s ground-breaking research will develop next-generation solutions where there are issues in medicine today, reducing the time it takes to bring new drugs to market or to determine medical diagnoses."

To watch a video news clip of the UT Arlington announcement, go to http://focus.ti.com/pr/docs/preldetail.tsp?sectionId=594&prelId=c08059.


Products  |  Applications  |  Support  |  Site Map
© Copyright 1995-2008 Texas Instruments Incorporated. All rights reserved. Trademarks  |  Privacy Policy  |  Terms of Use